(Q80164909)
Statements
A relationship between pharmacokinetics (PK) and the efficacy of infliximab for patients with rheumatoid arthritis: characterization of infliximab-resistant cases and PK-based modified therapy (English)
Shunsuke Mori
20 April 2007